2000
DOI: 10.1001/archderm.136.1.71
|View full text |Cite
|
Sign up to set email alerts
|

Melanoma and the Dermatologist in the Third Millennium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2002
2002
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 7 publications
(5 reference statements)
0
2
0
Order By: Relevance
“…Despite recent advances in immunotherapy and vaccinotherapy, chemotherapy remains the standard therapeutic option for disseminated melanoma (Mackie, 2000). However, MM frequently displays primary chemoresistance, and only a few cytotoxic drugs have shown activity against this tumor.…”
mentioning
confidence: 99%
“…Despite recent advances in immunotherapy and vaccinotherapy, chemotherapy remains the standard therapeutic option for disseminated melanoma (Mackie, 2000). However, MM frequently displays primary chemoresistance, and only a few cytotoxic drugs have shown activity against this tumor.…”
mentioning
confidence: 99%
“…Thus, multidrug resistance has been frequently observed in such cases, hence, new drugs with novel modes of action might help to increase the sensitivity of melanoma to chemotherapeutic treatments. 59 Since diospyrin analogues are known to induce apoptosis in several human cancer cell lines, it would be relevant to explore the mechanism of action of its glycosides in this respect. 34 Further, involvement of a ROS-mediated pathway was established, 35 revealing dramatic changes in mitochondrial transmembrane potential and other associated events signaling apoptotic cell death, in MCF-7 cells, caused by diospyrin diethyl ether.…”
Section: Antitumor Activitymentioning
confidence: 99%